1.A global perspective in asthma: from phenotype to endotype.
Chinese Medical Journal 2013;126(1):166-174
Asthma
;
drug therapy
;
epidemiology
;
etiology
;
China
;
epidemiology
;
Cluster Analysis
;
Humans
;
Phenotype
;
Pulmonary Eosinophilia
;
etiology
;
Smoking
;
adverse effects
;
Th2 Cells
;
immunology
2.Eosinophilic Peritonitis in a Patient with Continuous Ambulatory Peritoneal Dialysis (CAPD) .
Se Yong OH ; Hyang KIM ; Jeung Mook KANG ; Sung Ho LIM ; Hyun Duk PARK ; Soo Suk JUNG ; Kyu Beck LEE
The Korean Journal of Internal Medicine 2004;19(2):121-123
Eosinophilic peritonitis is defined as when there are more than 100 eosinophils present per milliliter of peritoneal effluent, of which eosinophils constitute more than 10% of its total WBC count. Most cases occur within the first 4 weeks of peritoneal catheter insertion and they usually have a benign and self-limited course. We report a patient of eosinophilic peritonitis that was successfully resolved without special treatment. An 84-year-old man with end stage renal disease secondary to diabetic nephropathy was admitted for dyspnea and poor oral intake. Allergic history was negative. and physical examination was unremarkable. Complete blood count showed a hemoglobin level of 11.1 g/dL, WBC count was 24, 500/mm3 (neutrophil, 93%; lymphocyte, 5%; monocyte, 2%), platelet count was 216, 000/mm3, serum BUN was 143 mg/dL, Cr was 5.7 mg/dL and albumin was 3.5 g/dL. Creatinine clearance was 5.4 mL/min. Three weeks after peritoneal catheter insertion, he was started on peritoneal dialysis with a 6-hour exchange of 2L 1.5% peritoneal dialysate. After nine days, he developed turbid peritoneal effluents with fever (38.4degrees C), abdominal pain and tenderness. Dialysate WBC count was 180/mm3 (neutrophil, 20%; lymphocyte, 4%; eosinophil, 76% [eosinophil count: 136/mm3]). Cultures of peritoneal fluid showed no growth of aerobic or anaerobic bacteria, or of fungus. Continuous ambulatory peritoneal dialysis (CAPD) was commenced, and he was started on intraperitoneal ceftazidime (1.0 g/day) and cefazolin (1.0 g/day). After two weeksr, the dialysate had cleared up and clinical symptoms were improved. Dialysate WBC count decreased to 8/mm3 and eosinophils were not detected in peritoneal fluid. There was no recurrence of eosinophilic peritonitis on follow-up evaluation, but he died of sepsis and pneumonia fifteen weeks after admission.
Aged, 80 and over
;
Anti-Bacterial Agents/therapeutic use
;
Cefazolin/therapeutic use
;
Ceftazidime/therapeutic use
;
Diabetic Nephropathies/complications
;
Eosinophilia/drug therapy/*etiology
;
Humans
;
Kidney Failure, Chronic/etiology/therapy
;
Male
;
Peritoneal Dialysis, Continuous Ambulatory/*adverse effects
;
Peritonitis/drug therapy/*etiology
3.Hypereosinophilia with Multiple Thromboembolic Cerebral Infarcts and Focal Intracerebral Hemorrhage.
Eun Ju LEE ; Young Jun LEE ; Seung Ro LEE ; Dong Woo PARK ; Hyun Young KIM
Korean Journal of Radiology 2009;10(5):511-514
We report a case of hypereosinophilia causing multiple areas of cerebral infarcts. A 52-year-old Korean man presented with dysarthria and weakness in both arms. A brain MRI revealed multiple acute infarcts in the distal border zone with focal intracerebral hemorrhage, whereas a cerebral angiogram was not remarkable. The eosinophil count was 5,500/microLiter and was accompanied by elevated cardiac enzyme levels. The pattern of cerebral infarcts and laboratory results suggest a thromboembolic infarction associated with hypereosinophilia.
Cerebral Hemorrhage/diagnosis/*etiology
;
Cerebral Infarction/diagnosis/*etiology
;
Diagnosis, Differential
;
Eosinophilia/*complications/drug therapy
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
4.A clinical study of eosinophilic meningoencephalitis caused by angiostrongyliasis.
Xiaotong WANG ; Hanjin HUANG ; Qiqian DONG ; Yan LIN ; Zongmin WANG ; Fangqu LI ; Yukifumi NAWA ; Kentars YOSHIMURA
Chinese Medical Journal 2002;115(9):1312-1315
OBJECTIVETo improve the clinician's awareness of angiostrongyliasis.
METHODSThe clinical and laboratory data as well as the epidemiological information concerning 18 patients with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis were analyzed.
RESULTSAll patients had a history of eating raw fresh water snail (Ampularium canaliculatus) before the onset of the disease. Incubation period ranged from 1 to 25 days. The major symptoms of the patients had severe headache and pain in the trunk and limbs. Increased eosinophlic count in peripheral blood and cerebrospinal fluid was noted. Tested by enzyme-linked immunoadsorbent assay (ELISA), sera were specifically IgG-antibody positive against Angiostrougylus cantonensis antigen, but were negative against other parasitic antigens such as Paragonimus westermani, Cysticerus, Cellulosae hominis, Echinococcus granulosus and Trichinella spiralis. Abnormal spotty signals were found in 2 cases with brain magnetic resonance imaging. Electroencephalogram (EEG) showed slow alpha rhythm. All the patients were effectively treated with combined administration of albendazole and dexamethazone.
CONCLUSIONSAngiostrongyliasis is one of the common causes leading to eosinophilic meningoencephalitis. To our knowledge, Wenzhou is the first small outbreak site of angiostrongyliasis discovered in Chinese mainland.
Adult ; Albendazole ; administration & dosage ; Angiostrongylus cantonensis ; Animals ; Dexamethasone ; administration & dosage ; Eosinophilia ; etiology ; Female ; Humans ; Male ; Meningoencephalitis ; etiology ; Middle Aged ; Prognosis ; Strongylida Infections ; complications ; drug therapy
5.A case of eosinophilic meningitis caused by cysticercosis of brain.
Chinese Journal of Pediatrics 2003;41(6):438-438
Animals
;
Antibodies, Helminth
;
blood
;
cerebrospinal fluid
;
Child, Preschool
;
Eosinophilia
;
cerebrospinal fluid
;
diagnosis
;
etiology
;
Female
;
Humans
;
Meningitis
;
cerebrospinal fluid
;
diagnosis
;
etiology
;
Neurocysticercosis
;
complications
;
drug therapy
;
parasitology
;
Taenia
;
immunology
6.Eosinophilic gastroenteritis presenting with duodenal obstruction and ascites.
Kian Chai LIM ; Hsien Khai TAN ; Andrea RAJNAKOVA ; Sudhakar Kundapur VENKATESH
Annals of the Academy of Medicine, Singapore 2011;40(8):379-381
Adult
;
Ascites
;
diagnosis
;
etiology
;
Biopsy
;
Diagnosis, Differential
;
Duodenal Obstruction
;
diagnosis
;
etiology
;
Endoscopy, Gastrointestinal
;
Enteritis
;
complications
;
drug therapy
;
Eosinophilia
;
complications
;
drug therapy
;
Gastritis
;
complications
;
drug therapy
;
Humans
;
Intestinal Mucosa
;
pathology
;
Male
;
Tomography, X-Ray Computed
7.A Case of Mexiletine-induced Hypersensitivity Syndrome Presenting as Eosinophilic Pneumonia.
Sang Pyo LEE ; Sang Heon KIM ; Tae Hyung KIM ; Jang Won SOHN ; Dong Ho SHIN ; Sung Soo PARK ; Ho Joo YOON
Journal of Korean Medical Science 2010;25(1):148-151
An 82-yr-old man was presented with fever and cough accompanied by generalized erythematous rash. He had taken mexiletine for 5 months, as he had been diagnosed with dilated cardiomyopathy and ventricular arrhythmia. Laboratory studies showed peripheral blood eosinophilia and elevated liver transaminase levels. Chest radiographs showed multiple nodular consolidations in both lungs. Biopsies of the lung and skin lesions revealed eosinophilic infiltration. After a thorough review of his medication history, mexiletine was suspected as the etiologic agent. After discontinuing the mexiletine and starting oral prednisolone, the patient improved, and the skin and lung lesions disappeared. Subsequently, mexiletine was confirmed as the causative agent based on a positive patch test. Drug-induced hypersensitivity syndrome is a severe adverse reaction to drugs and results from treatment with anticonvulsants, allopurinol, sulfonamides, and many other drugs. Several cases of mexiletine-induced hypersensitivity syndrome have been reported in older Japanese males with manifestation of fever, rash, peripheral blood eosinophilia, liver dysfunction without other organ involvement. Here, we report a case of mexiletine-induced hypersensitivity syndrome which presented as eosinophilic pneumonia in a Korean male.
Aged, 80 and over
;
Anti-Arrhythmia Agents/*adverse effects
;
Arrhythmias, Cardiac/drug therapy
;
Cardiomyopathy, Dilated/drug therapy
;
Drug Hypersensitivity/*diagnosis/etiology
;
Exanthema/pathology
;
Humans
;
Lung/pathology/radiography
;
Male
;
Mexiletine/*adverse effects
;
Pulmonary Eosinophilia/*chemically induced/*diagnosis
;
Syndrome
;
Tomography, X-Ray Computed
8.Kimura's Disease Involving the Ipsilateral Face and Extraocular Muscles.
Sang Joon LEE ; Ju Hwan SONG ; Shin Dong KIM
Korean Journal of Ophthalmology 2009;23(3):219-223
Kimura's disease (KD) is a rare, chronic inflammatory disorder, which is characterized by tumor-like masses mainly located in the head and neck region. Extraocular muscle involvement in KD is uncommon. We report a case of KD that involved both the extraocular muscles and buccal area. A 13-year-old male presented to our clinic with a two-year history of exophthalmos of the left eye and facial swelling. Facial CT and MRI showed a 1.5 x 1.5 cm2 soft tissue mass located at the left masticator and buccal area, exophthalmos of the left eye, and diffuse thickening of the left extraocular muscles. We performed a lateral rectus muscle incisional biopsy of the left eye. Oral methylprednisolone therapy was initiated and tapered following the incisional biopsy.
Administration, Oral
;
Adolescent
;
Angiolymphoid Hyperplasia with Eosinophilia/complications/*diagnosis/drug therapy/surgery
;
Cheek/*pathology
;
Edema/etiology
;
Exophthalmos/etiology
;
Face
;
Glucocorticoids/administration & dosage
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Methylprednisolone/administration & dosage
;
Oculomotor Muscles/*pathology/surgery
;
Postoperative Care
;
Treatment Outcome
9.Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Induced by Celecoxib and Anti-tuberculosis Drugs.
Joo Ho LEE ; Hye Kyung PARK ; Jeong HEO ; Tae Oh KIM ; Gwang Ha KIM ; Dae Hwan KANG ; Geun Am SONG ; Mong CHO ; Dae Sung KIM ; Hwal Woong KIM ; Chang Hun LEE
Journal of Korean Medical Science 2008;23(3):521-525
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome reflects a serious hypersensitivity reaction to drugs, characterized by skin rash, fever, lymph node enlargement, and internal organ involvement. So far, numerous drugs such as sulfonamides, phenobarbital, sulfasalazine, carbamazepine, and phenytoin have been reported to cause the DRESS syndrome. We report a case in a 29-yr-old female patient who had been on celecoxib and anti-tuberculosis drugs for one month to treat knee joint pain and pulmonary tuberculosis. Our patient's clinical manifestations included fever, lymphadenopathy, rash, hypereosinophilia, and visceral involvement (hepatitis and pneumonitis). During the corticosteroid administration for DRESS syndrome, swallowing difficulty with profound muscle weakness had developed. Our patient was diagnosed as DRESS syndrome with eosinophilic polymyositis by a histopathologic study. After complete resolution of all symptoms, patch tests were positive for both celecoxib and ethambutol. Although further investigations might be needed to confirm the causality, celecoxib and ethambutol can be added to the list of drugs as having the possibility of DRESS syndrome.
Adult
;
Anti-Inflammatory Agents, Non-Steroidal/adverse effects
;
Antitubercular Agents/adverse effects
;
Arthritis/complications/*drug therapy
;
Drug Eruptions/*etiology/pathology
;
Eosinophilia/*chemically induced/pathology
;
Ethambutol/*adverse effects
;
Female
;
Humans
;
Myositis/chemically induced/pathology
;
Pyrazoles/*adverse effects
;
Sulfonamides/*adverse effects
;
Syndrome
;
Tuberculosis, Pulmonary/complications/*drug therapy
10.Clinical Features of Eosinophilic Bronchitis.
Jae Hak JOO ; Sang Joon PARK ; Sung Woo PARK ; June Hyuk LEE ; Do Jin KIM ; Soo Taek UH ; Yong Hoon KIM ; Choon Sik PARK
The Korean Journal of Internal Medicine 2002;17(1):31-37
BACKGROUND: Eosinophilic inflammation of the airway is usually associated with airway hyper-responsiveness in bronchial asthma. However, there is a small group of patients which has the eosinophilic inflammation in the bronchial tree with normal spirometry and no evidence of airway hyper-responsiveness, which was named eosinophilic bronchitis. The objectives of this study are 1) to investigate the incidence of eosinophilic bronchitis in the chronic cough syndrome and 2) to evaluate the clinical features and course of eosinophilic bronchitis. METHODS: We evaluated 92 patients who had persistent cough for 3 weeks or longer. In addition to routine diagnostic protocol, we performed differential cell count of sputum. Eosinophilic bronchitis was diagnosed when the patient had normal spirometric values, normal peak expiratory flow variability, no airway hyper-responsiveness and sputum eosinophilia (>3%). RESULTS: The causes of chronic cough were post-nasal drip in 33%, cough variant asthma in 16%, chronic bronchitis in 15% and eosinophilic bronchitis in 12% of the study subjects. Initial eosinophil percentage in the sputum of patients with eosinophilic bronchitis was 26.8+/-6.1% (3.8-63.7%). Treatment with inhaled steroid is related with a subjective improvement of cough severity and a significant decrease of sputum eosinophil percentage (from 29.1+/-8.3% to 7.4+/-3.3%). During the follow-up period, increase in sputum eosinophil percentage with aggravation of symptoms were found. CONCLUSION: Eosinophilic bronchitis is one of the important cause of chronics cough. Assessment of airway inflammation by sputum examination is important in investigating the cause of chronic cough. Cough in eosinophilic bronchitis is effectively controlled by inhaled corticosteroid, but may follow a chronic course.
Adult
;
Aged
;
Anti-Inflammatory Agents, Steroidal/therapeutic use
;
Asthma/complications/epidemiology
;
Bronchitis/*complications/diagnosis/drug therapy/epidemiology
;
Budesonide/therapeutic use
;
Chronic Disease
;
Cough/epidemiology/*etiology
;
Eosinophilia/*complications/diagnosis/drug therapy/epidemiology
;
Female
;
Gastroesophageal Reflux/complications/epidemiology
;
Human
;
Male
;
Middle Age
;
Respiratory Function Tests
;
Severity of Illness Index
;
Sputum/chemistry/immunology